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Rotavirus is a major cause of mortality in developing countries, and yet the dynamics of rota-
virus in such settings are poorly understood. Rotavirus is typically less seasonal in the tropics,
although recent observational studies have challenged the universality of this pattern. While
numerous studies have examined the association between environmental factors and rotavirus
incidence, here we explore the role of intrinsic factors. By ﬁtting a mathematical model of
rotavirus transmission dynamics to published age distributions of cases from 15 countries,
we obtain estimates of local transmission rates. Model-predicted patterns of seasonal inci-
dence based solely on differences in birth rates and transmission rates are signiﬁcantly
correlated with those observed (Spearman’s r ¼ 0.65, p , 0.05). We then examine seasonal
patterns of rotavirus predicted across a range of different birth rates and transmission
rates and explore how vaccination may impact these patterns. Our results suggest that the
relative lack of rotavirus seasonality observed in many tropical countries may be due to
the high birth rates and transmission rates typical of developing countries rather than
being driven primarily by environmental conditions. While vaccination is expected to
decrease the overall burden of disease, it may increase the degree of seasonal variation in
the incidence of rotavirus in some settings.
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1. INTRODUCTION
Rotavirus is one of the leading causes of severe diar-
rhoea in children in both developed and developing
countries, and is estimated to cause over half a million
deaths worldwide with much of this mortality burden
concentrated in developing countries [1,2]. Two separ-
ate vaccines against rotavirus have been recently
developed and licensed in many countries throughout
the world. Early observations of vaccine impact in the
USA, Australia and several countries in Latin America
and Europe have highlighted the enormous promise
such vaccines hold for preventing rotavirus-associated
diarrhoea [3]. Clinical trials have estimated that vaccine
recipients beneﬁt from a 49–98% reduction in the risk of
severerotavirusdiarrhoeadependingonthesetting,with
lower efﬁcacy being observed in low-income regions
of Africa and Asia [4–10]. However, predicting the
population-level impact of vaccination and the impor-
tance of herd immunity requires an understanding of
the dynamics of infection. This can be achieved through
mathematical modelling studies rooted in biological and
epidemiological data [11–16].
The spatio-temporal patterning of disease can
provide important insight into the underlying transmis-
sion dynamics of infections. Using a mathematical
model for the transmission dynamics of rotavirus, we
have previously shown that the apparent travelling
wave of rotavirus infection in the USA from southwest
to northeast may be due to underlying geographical
variability in birth rates [13]. This pattern is no
longer apparent in the post-vaccination era, suggesting
that susceptible recruitment rather than environmen-
tal factors plays a key role in determining the timing
of rotavirus activity in the US [17]. The model can
also explain the much diminished and delayed peak in
rotavirus activity observed during the 2007–2008
season following the licensing of the RotaTeq vaccine
in the US in 2006, providing an important source of
model validation [13,18,19]. Furthermore, the model
allows quantiﬁcation of the relative importance of
direct and indirect (herd immunity) protection, which
is essential in determining the long-term impact of
*Author for correspondence (vepitzer@princeton.edu).
Electronic supplementary material is available at http://dx.doi.org/
10.1098/rsif.2011.0062 or via http://rsif.royalsocietypublishing.org.
J. R. Soc. Interface (2011) 8, 1584–1593
doi:10.1098/rsif.2011.0062
Published online 20 April 2011
Received 2 February 2011
Accepted 28 March 2011 1584 This journal is q 2011 The Royal Societyvaccination [13]. However, these results are not directly
applicable to the situation of developing countries. Rou-
tine immunization against rotavirus has only been
introduced in developed countries, South Africa, and
a handful of developing countries in Latin America
thus far. While the majority of rotavirus deaths occur
in the poorest nations, the impact of vaccination in
such settings remains unclear.
There are several reasons why the dynamics of rota-
virus infection may differ in developing countries
compared with developed countries. Many developing
countries are located in the tropics where traditionally
rotavirus activity has been thought to lack seasonality,
leading to high levels of year-round disease transmission
[20]. However, recent country-level assessments of rota-
virus epidemiology conducted in anticipation of
rotavirus vaccination programmes suggest that this pat-
tern may not be as universal as previously thought.
Rotavirus tends to be more common in cooler, drier
months in most settings, but seasonal peaks have
been noted to occur year-round in different countries
[21–23], and can vary over time in the same country
[24]. Attempts to relate these patterns to climatic vari-
ables such as temperature, humidity and rainfall have
led to conﬂicting results; it is possible the effect of
certain climatic variables is context speciﬁc [25–28].
Birth rates have been shown to be an important
driver of the dynamics of rotavirus in the US [13], and
are likely inﬂuential in developing countries as well.
Birth rates are often considerably higher in developing
countries compared with developed countries, ranging
as high as 45–50 live births per 1000 persons in parts
of Asia and sub-Saharan Africa, compared with 8–20
per 1000 in developed countries [29]. Crowding and
poor sanitation are also expected to increase rates of
rotavirus transmission [30,31]. While temperature and
humidity tend to exhibit less seasonal variation in
developing countries in the tropics, other factors such
as precipitation, population movements and birth
rates may be more seasonally variable in such settings
[32,33]. Our best-ﬁt model to rotavirus hospitalization
and laboratory data in the USA indicated that small
seasonal changes in the transmission rate (approx. 5%
seasonal amplitude) could explain the highly seasonal
pattern of outbreaks [13]. Natural oscillations resulting
from the replenishment of susceptible individuals
through new births and/or waning of immunity—a
phenomenon known as dynamical resonance—may be
a key factor in explaining the seasonality of rotavirus,
as in other diseases [34,35]. Overall, the environmental
and demographic factors driving seasonality in rota-
virus transmission have yet to be fully elucidated
and quantiﬁed.
Here, we used a combination of mathematical models
for rotavirus transmission and empirical data to exam-
ine how seasonal patterns of disease incidence vary
with birth rates and mean transmission rates indepen-
dent of variations in environmental factors. We tested
the hypothesis that dynamic resonance can explain
some or all of the observed geographical variation in
rotavirus seasonality. By ﬁtting our model of rotavirus
transmission to the age distribution of rotavirus-associ-
ated diarrhoea cases from a variety of countries, we
obtained estimates of mean transmission rates in these
settings and validated predictions of rotavirus season-
ality against observed data. We then explored how
vaccination may impact seasonal patterns of rota-
virus incidence if existing vaccines are introduced in
more countries.
2. METHODS
2.1. Epidemiological data
To obtain estimates of mean rotavirus transmission
rates in different settings, we ﬁt our model to published
age distributions of rotavirus cases less than 5 years of
age (an age range in which approx. 95% of reported
cases occur) from 15 countries representing eight
regions of the world [11,13,36–48]. To identify rotavirus
surveillance studies which included a description of the
seasonal pattern and age distribution of cases, we con-
ducted a literature search using Web of Science. We
limited our analysis to those studies that were published
between 2005 and 2010 and reported the number of
conﬁrmed rotavirus diarrhoea cases by month (or
number of tests and per cent of tests positive for rota-
virus) over a period of at least 2 years, or for which
such data were available from other sources [49–51].
We also required that the studies included data on
either numbers or proportions of rotavirus-positive
cases of acute gastroenteritis by age, with at least six
month age resolution less than 1 year of age and 1
year age resolution up to 5 years of age. We used
DIGITIZEIT software (Bormann; www.digitizeit.de)t o
extract data from ﬁgures when the data were not avail-
able from tables. The quality and nature of rotavirus
surveillance varies from country to country and across
time; some studies tracked only hospitalized rotavirus
cases, while others sampled both inpatient and outpati-
ent populations. By examining the proportion of cases
in each age class, we can control for differences in
surveillance, provided biases in reporting are not related
to the age of cases.
We obtained birth rate data from the World Popu-
lation Prospects database [29] and assumed the birth
rate in each country was constant over time and equal
to the mean crude birth rate (CBR) for the 5 year
periods prior to and including the study period. The
background mortality rate was assumed to be equal to
the birth rate and independent of age, so that the
total population size remained constant. We ignored
disease-induced mortality, which will not affect our
estimates of the transmission rate provided mortality
does not signiﬁcantly shorten the infectious period.
2.2. Transmission model
Details of our age-structured model for the transmission
dynamics of rotavirus are presented in the electronic
supplementary material and have been described pre-
viously [13]. In short, we assume that susceptible
individuals are infected, recover and are temporarily
immune, then become susceptible again, with reduced
susceptibility to infection and disease following one or
more previous infections. We assume that only primary
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which is subsequently reported. After that, we assume
individuals only experience asymptomatic (or mildly
symptomatic) infections that are less infectious and
not reported. After examining the age distributions of
cases from different countries, we modiﬁed the model
to more accurately capture the nature of maternal
immunity (and/or limited exposure to rotavirus
during the ﬁrst 6 months of life due to social/behaviour-
al factors). Maternal immunity appeared to be stronger
than previously assumed, as indicated by a relative
dearth of cases in the zero to ﬁve months age group,
particularly in the lowest income countries. Thus, we
split the maternal immunity compartment into six sep-
arate compartments and estimated a common duration
of time spent in each compartment by ﬁtting the model
to the mean age distribution of cases from all countries
combined (see the electronic supplementary material).
The rotavirus transmission rate was assumed to vary
sinusiodally with a period of 1 year as follows: b(t) ¼
b0(1 þ acos(2p(t 2 w))), where, b0 is the baseline
transmission rate, a is the amplitude of seasonality and
w is a seasonal offset parameter. Mixing was assumed
to be homogeneous, such that b0 was the same for all
age groups. We examined the sensitivity of our results
to this assumption in the electronic supplementary
material. The sinusoidal variation in the transmission
rate is presumably related to environmental factors
that could inﬂuence rotavirus transmission, such as the
effect of temperature or humidity on virus survival or
increased population crowding during cold or rainy
months. However, the factors inﬂuencing this have yet
to be fully elucidated. We varied the birth rate and base-
line transmission rate while holding the amplitude of
seasonal variation in the transmission rate, a, constant
at 5 per cent, a level similar to that estimated for the
USA. This allowed us to examine seasonality in the inci-
dence of severe rotavirus diarrhoea predicted by the
model independent of environmental factors. Other
dynamic models for rotavirus have estimated the
amplitude of seasonal variation in the transmission
rate to be similar albeit slightly higher in England and
Wales (a ¼ 9.2%) [11] and Kyrgyzstan (a ¼ 7.9%) [12].
If seasonal variation in the transmission rate is tied to
factors such as temperature and humidity, however, it
might be expected to exhibit lower amplitude in the tro-
pics. We conducted sensitivityanalyses with a ¼ 2.5 and
10%, and examined the effect of modelling seasonal vari-
ation in the transmission rate using a step function (see
the electronic supplementary material).
The degree of seasonal ﬂuctuation in incidence (s)
predicted by the model was measured as:
s ¼
xmax     x
  x

  100%;
where xmax is the peak number and   x is the mean
number of clinical rotavirus cases per week (in all age
groups) over a 2 year period, to account for the possible
occurrence of biennial epidemics. To quantify the
observed seasonality, we ﬁrst aggregated the data by
month of the year then compared the mean rotavirus
incidence in the three months surrounding the peak to
the mean incidence for the entire 12 month period to
limit the inﬂuence of stochastic variation in the
number of rotavirus cases.
We calculated the basic reproductive number of
primary infections, R0, and used it as a measure of
transmissibility (see the electronic supplementary
material). We ﬁrst examined the dynamics of rotavirus
epidemics predicted by the model at the observed birth
rate and estimated R0 for each of the 15 countries, then
across CBRs ranging from ﬁve to 50 live births per 1000
and R0 ranging from 20 to 100, consistent with most of
the estimated global variation in these parameters
(table 1).
2.3. Impact of vaccination
We then examined the impact of vaccination on pat-
terns of rotavirus disease incidence predicted by the
Table 1. Summary of model parameters and seasonal patterns for 15 countries.
country (reference(s)) study years
CBR (live
births per 1000)
estimated R0
(95% CI)
estimated seasonality,
%( rank)
observed
seasonality, % (rank)
inpatient studies
Australia [43,50,51] 1997–2007 13.4 53.9 (52.2, 55.6) 54 (10) 104 (10)
Taiwan [48] 2005–2007 12.0 23.3 (20.4, 26.2) 140 (14) 102 (9)
USA [13] 1998–2004 14.8 45.3 (44.8, 45.8) 73 (12) 179 (13)
China [40] 2003–2007 13.7 88.1 (83.4, 93.4) 20 (4)9 8 ( 7)
Nepal [46] 2005–2007 27.9 51.3 (43.2, 61.9) 25 (5) 100 (8)
Uzbekistan [41] 2005–2006 21.0 46.7 (42.4, 51.5) 40 (8)6 3 ( 5)
Hong Kong SAR [44] 2001–2003 8.4 52.1 (48.7, 55.4) 145 (15) 132 (11)
Cambodia [45] 2005–2007 25.4 68.5 (62.0, 76.1) 16 (3)4 6 ( 4)
Fiji [42] 2006–2007 22.1 46.2 (36.8, 58.6) 39 (7) 178 (12)
Lao PDR [36] 2005–2007 28.4 34.3 (30.4, 38.8) 49 (9) 241 (15)
outpatient and inpatient studies
England and Wales [11,49] 1999–2009 12.0 54.4 (54.0, 54.8) 61 (11) 182 (14)
Bangladesh [47] 1993–2004 30.9 72.2 (68.4, 76.4) 11 (2)4 2 ( 2)
Malawi [39] 1997–2007 45.1 191 (137, 313) 2 (1)1 5 ( 1)
Nigeria [37] 2002–2004 42.7 37.0 (27.5, 51.9) 26 (6)4 6 ( 3)
Philippines [38] 2005–2006 25.7 27.9 (24.4, 31.6) 110 (13)9 4 ( 6)
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comparable to that of primary infection, as in our
previous model [13], resulting in an 80 per cent
reduction in the risk of severe diarrhoea in previou-
sly uninfected infants. Vaccine efﬁcacy was not an
input parameter, but this level of protection is similar
to that estimated during Rotarix trials in Latin
America [5]. Vaccine efﬁcacy estimates in developing
countries of Asia and Africa, however, have been
lower [4,6,10]; this can be considered equivalent to a
lower effective coverage level in our model. We
examined the impact of vaccination at coverage levels
of 50, 70 and 90 per cent on the mean and peak
incidence of severe diarrhoea during a 2 year period
beginning 5 years after the introduction of the
vaccine across the full range of birth rates and
transmission rates.
Finally, we examined model predictions regarding
the proportion of infants infected prior to four months
of age across the full range of birth rates and trans-
mission rates and how this was impacted by
vaccination. One possible explanation for the reduced
efﬁcacy of rotavirus vaccination in recent trials con-
ducted in developing countries is the high rate of
exposure to circulating virus in the placebo group
prior to enrolment combined with limited immuno-
genicity of the vaccine in previously infected infants
[6]. If vaccination mimics natural infection but does
not provide any added beneﬁt beyond the immunity
generated by a primary rotavirus infection, or if
recent infection interferes with vaccine-induced immu-
nity, then it is possible that the observed vaccine
effectiveness may be reduced in relation to the
proportion of infants infected prior to the age of vaccine
administration.
3. RESULTS
Fitting of the model to age distributions of cases from
15 countries yielded estimates of R0 ranging from 23.3
to 191 (table 1). Estimates of R0 were typically lower
for more developed countries than they were for devel-
oping countries, where a high proportion of cases
occurred in infants less than 1 year of age (ﬁgure 1).
The degree of seasonal ﬂuctuation in incidence observed
was similar to that predicted by the model, although
the magnitude of seasonal ﬂuctuation was greater in
the observed data than in the model predictions
(table 1); this is not unexpected given that the stochas-
ticity in the data will clearly affect this measure. If we
increased the amplitude of seasonal forcing in the
model to 10 per cent, we could better capture the
observed magnitude of seasonal variation in most cases
(see the electronic supplementary material, ﬁgure S3).
Regardless of the amplitude of seasonal forcing, the
observed and predicted seasonality ranks were signiﬁ-
cantly correlated (Spearman’s correlation: r ¼ 0.65,
p , 0.05; table 1).
The degree of seasonal ﬂuctuation in the incidence of
severe rotavirus diarrhoea predicted by the model
varied substantially depending on both the birth rate
and transmission rate (ﬁgure 2 contour map). Seasonal-
ity, independent of the degree of seasonal forcing,
was greatest for combinations of low-to-intermediate
birth rates and low-to-intermediate transmission rates.
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Figure 1. Fitofthemodeltoagedistributionsofcasesfrom15countries.Theobservedproportionofreportedcasesinthezerotoﬁve
month,sixto11month,1,2,3and4yearoldagegroupsarerepresentedbytheblackbars,whilethewhitebarsarethosepredictedby
the model. Developed countries are in the top line, while developing countries are in the bottom two lines. Within these groups,
countries are ordered by distance from the equator (greatest to least); temperate countries are in the shaded region.
Rotavirus seasonality V. E. Pitzer et al. 1587
J. R. Soc. Interface (2011)A region of strong seasonality was also noted when both
birth rates and transmission rates were very low
(CBR , 10 live births per 1000 and R0 , 30); further
exploration revealed that epidemics occurred biennially
in this parameter region. When birth rates and trans-
mission rates were high (e.g. CBR . 30 live births per
1000 and R0 . 50), the degree of seasonal ﬂuctuation
in incidence was predicted to be low (less than 25%).
The parameter regions of strong seasonality varied
only slightly with the strength of seasonal forcing (a)
and were not sensitive to the functional form (sinusoi-
dal or step), while the degree of seasonal ﬂuctuation
in incidence varied proportionally with a, as expected
(see the electronic supplementary material).
Since vaccination roughly equates to a decline in the
birth rate by reducing the recruitment of fully suscep-
tible individuals and a reduction in the transmission
rate by preventing the most infectious primary cases,
we might predict from ﬁgure 2 that vaccination could
increase the seasonality of epidemics under certain cir-
cumstances. Vaccination led to a decrease in the
average annual incidence of severe diarrhoea predicted
by the model that was comparable across all birth
rates and transmission rates we explored. Under most
circumstances, vaccination was also expected to
decrease the peak incidence of severe diarrhoea in a
typical post-vaccination year (ﬁgure 3). However, for
certain combinations of birth rates and transmission
rates, vaccination could indeed lead to an increase in
the peak incidence of severe diarrhoea occurring at cer-
tain times of the year as the dynamics transitioned to a
pattern of more seasonal epidemic disease or biennial
epidemics. This is illustrated for the case of a country
with an intermediate birth rate (CBR ¼ 20 live births
per1000) andtransmission rate(R0 ¼ 35)withavaccine
coverage of 50 per cent (ﬁgure 3b). As vaccine coverage
increased, the relative peak incidence tended to decrease
across all combinations of birth rates and transmission
rates, but countries with higher birth rates and/or trans-
mission rates became more at risk for increased peak
seasonal incidence (ﬁgure 3a). Furthermore, there may
be a transition period soon after vaccine introduction
in which seasonal incidence is more pronounced.
Those countries most at risk for increased peak
incidence following the introduction of rotavirus vacci-
nation are ones with intermediate birth rates and
transmission rates. Given our estimates of R0 for the
representative countries with published age distribu-
tions, this may include countries such as Uzbekistan.
Countries such as Cambodia and Nepal with slightly
higher birth rates and transmission rates could experi-
ence similar phenomena as vaccine coverage levels
reach 90 per cent or more, with a vaccine efﬁcacy of
80 per cent. However, it may be difﬁcult to achieve
this level of effective coverage if the vaccine is less
efﬁcacious in such settings.
The proportion of infants infected prior to four
months of age also showed a strong dependence on
both the birth rate and the transmission rate (ﬁgure 4).
At high birth rates and transmission rates, up to 12 per
cent of infants may be infected with rotavirus prior to
four months of age, which is the recommended age at
which the second dose of rotavirus vaccine is adminis-
tered in most developed countries (ﬁgure 4a). Thus,
vaccination may not have as great an impact initially
in such settings if vaccination is not as effective in
previously infected infants. However, vaccination is
expected to lead to a decrease in the force of infection
(i.e. incidence rate per susceptible individual) and thus
a delay in the time to infection, such that the proportion
ofinfantsinfectedpriorto4monthsofagedecreasedsub-
stantially at high levels of vaccine coverage (ﬁgure 4b).
This could lead to an increase in vaccine impact over
time under these assumptions.
4. DISCUSSION
Much of the promise of rotavirus vaccines lies in their
ability to reduce the incidence of severe disease in
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J. R. Soc. Interface (2011)developing countries, where diarrhoea is still a major
cause of both morbidity and mortality [1,2]. Determin-
ing how the potential impact of vaccination may vary
between developed versus developing countries requires
an understanding of how the transmission dynamics
of rotavirus differ in these settings. Birth rates have
been shown to be an important determinant of the
spatio-temporal pattern of rotavirus epidemics in the
USA [13], and may also help explain why rotavirus
tends to be less seasonal in developing countries,
which often exhibit high birth rates and high trans-
mission rates. Using a mathematical model ﬁtted to
epidemiological data from 15 countries, we show that
geographical differences in birth and transmission
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rotavirus seasonality. Our model also suggests that
vaccination could have the unexpected consequence
of increasing the seasonality of rotavirus disease in
countries with intermediate-to-high birth rates and/or
transmission rates while still reducing the mean
annual incidence of disease.
While the combination of birth rates and trans-
mission rates are likely important determinants of the
magnitude of seasonal variation and can affect small
differences in the timing of epidemics, these factors do
not explain why rotavirus tends to occur more fre-
quently during the cool, dry season in both temperate
and tropical regions [20,22,23]. Environmental factors
such as temperature and/or humidity probably play a
role in organizing the peak of rotavirus transmission
to times when conditions are most favourable to virus
survivability and transmission [25–28]. However, even
small seasonal differences in the transmission rate can
resonate with the epidemic clockwork to produce large
seasonal epidemics evident in some countries. It should
be noted that these large seasonal epidemics are not
conﬁned to temperate regions of the world, as previou-
sly thought [20]. Pronounced seasonality has been
observed in subtropical and tropical countries, such as
Hong Kong and Taiwan (since 2005) [44,48], as well as
regions of Venezuela and Brazil [52,53]. By contrast,
temperate countries such as Uzbekistan exhibit only
weak seasonal variation in rotavirus incidence [41]. The
combination of lower birth rates and/or lower trans-
mission rates may help in explaining why rotavirus
tends to be moderately to strongly seasonal in countries
such as Hong Kong and the Lao PDR, but is only
weakly seasonal in neighbouring Cambodia (table 1
and electronic supplementary material, ﬁgure S1)
[36,44,45]. Our results also indicate that infection tends
to occur at an earlier age when birth rates and trans-
mission rates are high. Thus, the observed association
between year-round circulation of rotavirus and a
lower average age of cases may be confounded by the
common causes of high birth rates and/or transmission
rates rather than being indicativeof acausal relationship
between seasonality and age of infection [53,54].
The effect of vaccination is dynamically similar to a
reduction in the birth rate since the number of fully sus-
ceptible infants entering the population is decreased
and a reduction in the transmission rate since it pre-
vents the most infectious primary cases [13]. This
helps explain why epidemics occurred later and with
lower amplitude following the introduction of rotavirus
vaccination in countries such as the USA and Mexico
[18,19,55], since vaccination led to a delay in the
build-up of a sufﬁcient number of susceptible infants
and highly infectious primary cases to set off an epi-
demic. Our model suggests vaccination may alter the
dynamics of rotavirus in countries with intermediate
birth rates and transmission rates, leading to a pattern
of more seasonal epidemic disease. While the overall
annual incidence of rotavirus diarrhoea is expected to
decrease, peak seasonal incidence of rotavirus could
actually increase in such settings. It is important to
anticipate these changes in the dynamics, particularly
if hospitals are not equipped to handle the increased
number of diarrhoea admissions at the peak of the
epidemic. This could also impact cost-effectiveness ana-
lyses, since the cost of hospitalization may increase, for
example, if there is a shortage of beds. Finally, it will be
important to evaluate the success of rotavirus vacci-
nation in terms of the reduction in annual morbidity
and mortality measures rather than comparing monthly
indicators to their pre-vaccination levels. The occur-
rence of epidemics following the introduction of
rotavirus vaccination to a country should not be con-
sidered indicative of vaccine failure. To avoid such
effects, countries with intermediate birth rates and
transmission rates most at risk for increased seasonal
incidence may want to ensure that high levels of vaccine
coverage are reached as quickly as possible after vaccine
introduction.
In developing countries with high birth rates and
transmission rates, achieving high coverage with a fully
effective vaccine may not be as feasible. In recent clinical
trials, the efﬁcacy of rotavirus vaccination was lower in
some developing country settings [4,6,10]. There are a
number of possible explanations for this reduced efﬁcacy
related to host and environmental factors, including
higher rates of breastfeeding and higher levels of
transplacental maternal antibodies, co-administration
of oral polio vaccine, interference by other diarrhoeal
pathogens, micronutrient malnutrition and greater
diversity of rotavirus strains in developing countries
[56]. Furthermore, the high transmission rate and year-
round circulation of rotavirus in such settings may lead
to infection prior to enrolment in vaccine trials and/or
the administration of all vaccine doses, as we show here.
This could contribute to lower efﬁcacy estimates if the
effect of vaccination is reduced in previously infected
individuals, although it is unlikely to explain all of the
observed effect. Nevertheless, even moderately efﬁca-
cious vaccines can prevent considerable numbers of
hospitalizations and deaths due to rotavirus in these
highburdensettings[4,6,10].Ifvaccinationisintroduced
insuchcountriesatappreciablecoveragelevels,itisposs-
ible that the observed vaccine effectiveness may actually
increase over time as the force of infection is reduced,
thereby leading to a delay in the time to ﬁrst infection;
this is an important consequence of the ‘herd immunity’
generated by vaccination. Furthermore, if mothers in
developing countries tend to have higher maternal anti-
body titres as a result of continual boosting by exposure
to rotavirus, then this reduction in the force of infection
may also decrease the neutralizing effect these maternal
antibodies could be having on the vaccinewhen adminis-
tered to infants.
The ﬁt of our model to the age distribution of cases
in different countries reveals an element of added com-
plexity in the nature of maternal immunity and
protection against rotavirus. The strength and duration
of maternal immunity appear to be greater than pre-
viously assumed in models of rotavirus transmission
[11,13,16]. This is particularly evident in the age distri-
butions of cases from developing countries, where the
greatest proportion of cases occurs in the six to 11
months age group, but the zero to ﬁve months age
group is comparatively underrepresented. It is possible
that maternal immunity tends to be long-lasting in
1590 Rotavirus seasonality V. E. Pitzer et al.
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becauseofthecombinationofhigherratesandlongerdur-
ation of breastfeeding, and possible immune boosting in
mothers resulting from more recent re-infection (and/or
recent infection with a greater diversity of strains).
Further exploration of these differences is warranted as
it could help explain the reduced efﬁcacy of vaccination
in developing countries.
Surveillance studies conducted in anticipation of
rotavirus vaccination have yielded descriptions of the
age distribution and seasonal pattern of rotavirus-
associated diarrhoea in children less than 5 years of age
from a variety of different countries. We used these age
distributions to estimate the transmission rate of rota-
virus in these settings given the birth rate is known; our
estimates range between R0 ¼ 28 and R0 ¼ 191. These
estimates should not be over-interpreted and will prob-
ably be biased in some instances. Other factors are
likely to affect the reported age distribution of rotavirus
cases from which these estimates were derived, such as
differences in treatment-seeking behaviour, the preva-
lence of co-infections which may affect rotavirus testing
rates, mortality patterns and other population demo-
graphics, infant care practices, population mixing, etc.
Furthermore, surveillance methods differed from study
to study. While some studies only tested patients
admitted to the hospital or clinic, others tested both
inpatients and outpatients; there may be differences in
theagedistributionandreportingrateofsevererotavirus
cases compared with those with more moderate diar-
rhoea. Greater representation of moderate diarrhoea
cases in older age individuals could lead to underestima-
tion of R0 in studies that included outpatients. The
duration of surveillance also differed among studies,
and the age distribution and seasonality of rotavirus
diarrhoea in a given year may not be indicative of
long-term patterns.
Our modelling assumptions will also affect our esti-
mates of the transmission rate. For example, we
assumed mixing is homogeneous, but other population
mixing assumptions may lead to lower estimates of R0
(see the electronic supplementary material). Also, we
assumed that birth rates and transmission rates were
constant over time when in fact they are likely to have
changed. Our model is in part based on estimates of
natural immunity from infection derived from a
cohort study conducted in Mexico [57]. While other
studies have demonstrated similar ﬁndings [58,59], the
strength of natural immunity from previous rotavirus
infections may not be the same in all settings, and in
particular may be weaker in some developing countries.
Furthermore, we assumed that disease severity is
related to the number of previous infections rather
than the age of infected individuals; it is very difﬁcult
to disentangle these two highly correlated effects. If
rotavirus infections tend to be less severe in older chil-
dren independent of the number of previous infections,
then we may be overestimating the transmission rate
in some settings, as well as underestimating the
impact of vaccination [13].
Nevertheless, the estimates of the transmission rate
which we derive are useful in that they allow us to com-
pare patterns of rotavirus seasonality predicted by the
model for different settings using very limited data.
More reliable estimates of the transmission rate, as
well as estimates of seasonal variation in the trans-
mission rate and underreporting factors, can and
should be obtained by ﬁtting models to age-stratiﬁed
time series of rotavirus cases from speciﬁc settings.
Anticipating the country-speciﬁc impact of vaccination
requires an understanding of how vaccine effectiveness
and the transmission dynamics of rotavirus may vary
among settings and over time.
Determining how and why seasonal patterns of rota-
virus-associated diarrhoea differ between developed and
developing countries is an important element in evalu-
ating how the impact of vaccination observed
presently in the Americas, Australia and Europe may
translate to the context of developing countries [3].
The relationship we describe between birth rates, trans-
mission rates and the degree of seasonal ﬂuctuation in
rotavirus incidence predicted by our model helps to
broaden this understanding. However, other factors
remain unexplained, such as what are the environ-
mental and other sources of seasonal forcing that lead
to rotavirus being more common in the cool, dry
season in most parts of the world? Additionally, why
is a greater diversity of rotavirus strains observed in
developing countries compared with developed
countries, and how will this impact vaccine effective-
ness? Mathematical modelling of the transmission
dynamics of rotavirus may help to address some of
these questions, but further epidemiological and exper-
imental studies are essential in improving our
understanding of these issues and will help to inform
future models for rotavirus dynamics.
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